Eszopiclone Co-Administered With Fluoxetine in Patients With Insomnia Coexisting With Major Depressive Disorder
Biological PsychiatryPublished 5 April 2006
Maurizio Fava, W. Vaughn McCall, Andrew D. Krystal, Thomas Wessel, Robert Rubens, Judy Caron
Citations469
SJR quartileQ1
SJR score4.68
SNIP2.24
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
Eszopiclone/fluoxetine co-therapy was relatively well tolerated and associated with rapid, substantial, and sustained sleep improvement, a faster onset of antidepressant response on the basis of CGI, and a greater magnitude of the antidepressant effect.
Abstract
In this study, eszopiclone/fluoxetine co-therapy was relatively well tolerated and associated with rapid, substantial, and sustained sleep improvement, a faster onset of antidepressant response on the basis of CGI, and a greater magnitude of the antidepressant effect.
Keywords
PsychologySocial SciencesMedicine
Journal of Neurology Neurosurgery & PsychiatryA RATING SCALE FOR DEPRESSION
32,633 Citations1960M. Hamilton
The present scale has been devised for use only on patients already diagnosed as suffering from affective disorder of depressive type, used for quantifying the results of an interview, and its value depends entirely on the skill of the interviewer in eliciting the necessary information.
Elsevier eBooksPrinciples and Practice of Sleep Medicine
5,133 Citations2011Meir H. Kryger, Thomas Roth +1 more
JAMAEpidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention?
2,453 Citations1989Daniel E. Ford
Medical Entomology and ZoologyInsomnia: Psychological Assessment and Management
2,354 Citations1993Charles M. Morin
JAMAEpidemiologic Study of Sleep Disturbances and Psychiatric Disorders
2,251 Citations1989Daniel E. Ford
As part of the National Institute of Mental Health Epidemiologic Catchment Area study, 7954 respondents were questioned at baseline and 1 year later about sleep complaints and psychiatric symptoms using the Diagnostic Interview Schedule.
SLEEPSustained Efficacy of Eszopiclone Over 6 Months of Nightly Treatment: Results of a Randomized, Double-Blind, Placebo-Controlled Study in Adults with Chronic Insomnia
621 Citations2003Andrew D. Krystal, James K. Walsh +5 more
Throughout 6 months, eszopiclone improved all of the components of insomnia as defined by DSM-IV, including patient ratings of daytime function, which is compelling evidence that long-term pharmacologic treatment of insomnia is efficacious.
Acta Psychiatrica ScandinavicaQUANTITATIVE RATING OF DEPRESSIVE STATES
490 Citations1975Per Bech, L. F. Gram +4 more
A step‐by‐step analysis of Beck's and Hamilton's rating scales showed that both, scales failed to differentiate adequately between moderate and severe depression measured by a global clinical assessment.
The Journal of Clinical PsychiatryResidual Symptoms in Depressed Patients Who Respond Acutely to Fluoxetine
464 Citations1999Andrew A. Nierenberg, Bronwyn R. Keefe +6 more
The high prevalence of residual symptoms among antidepressant responders suggests the need for further study including whether residual symptoms abate with longer treatment or increased dose of fluoxetine.
Current Medical Research and OpinionEfficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia
294 Citations2004Gary Zammit, Louis J. McNabb +3 more
Patients treated with nightly eszopiclone 3 mg had better polysomnographic and patient-reported measures of sleep over the 6-week trial and no detrimental effects on next-day psychomotor performance using the DSST.
PubMedDaytime sleepiness and insomnia as correlates of depression.
246 Citations2004Maurizio Fava
The relationships between insomnia and depression and the effects of various antidepressants on sleep are described and several different treatment options, including antidepressant monotherapy and augmentation of antidepressants with other medications, are explored.
The Journal of Clinical PsychiatrySleep Disturbances and Suicidal Behavior in Patients With Major Depression
227 Citations1997Mehmed YoEargon, Hayrettin Kara +1 more
It is demonstrated that both insomnia and hypersomnia are associated with suicidal behavior in patients with major depression.
Sleep MedicineAn evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia
225 Citations2005Thomas Röth, Jared P. Walsh +3 more
Significant improvements in sleep and daytime function were evident in those switched from double-blind placebo to 6 months of open-label eszopiclone therapy and were sustained during the 6 years ofopen-label treatment for those receiving prior double- blind eszopylone.
BMJAcute treatment of moderate to severe depression with hypericum extract WS 5570 (St John's wort): randomised controlled double blind non-inferiority trial versus paroxetine
218 Citations2005Armin Szegedi, Ralf Kohnen +2 more
In the treatment of moderate to severe major depression, hypericum extract WS 5570 is at least as effective as paroxetine and is better tolerated.
PubMedAntidepressant treatment of the depressed patient with insomnia.
208 Citations1999Michael E. Thase
Early relief of insomnia in a depressed patient, in addition to alleviating other symptoms, may increase adherence to treatment and increase daytime performance and overall functioning, while complete relief ofomnia may improve prognosis.
Treatment of Late-Life Insomnia
205 Citations2000Kenneth L. Lichstein, Charles M. Morin
Insomnia in Dementia and in Residential Care, Characteristics of Older Adults with Insomnia, and Special TREATMENT TOPICS.
The Journal of Clinical PsychiatryZolpidem for Persistent Insomnia in SSRI-Treated Depressed Patients
174 Citations1999Gregory M. Asnis, Amil Chakraburtty +7 more
In this defined patient population, zolpidem, 10 mg, was effectively and safely co-administered with an SSRI, resulting in improved self-rated sleep, daytime functioning, and well-being.
SLEEPA 2-Week Efficacy and Safety Study of Eszopiclone in Elderly Patients with Primary Insomnia
139 Citations2005Martin B. Scharf, Milton K. Erman +5 more
American Journal of PsychiatryShort-Term Augmentation of Fluoxetine With Clonazepam in the Treatment of Depression: A Double-Blind Study
103 Citations1998W T Smith, Peter D. Londborg +2 more
This strategy may reduce suffering during early SSRI treatment, may partially suppress SSRI side effects, may increase compliance, and could possibly reduce the risk of suicide.
Journal of Affective DisordersShort-term cotherapy with clonazepam and fluoxetine: anxiety, sleep disturbance and core symptoms of depression
100 Citations2000Peter D. Londborg, Ward T. Smith +2 more
Low-dose cotherapy of fluoxetine with clonazepam was safe and accelerated response over 21 days of treatment, decreasing anxiety and sleep disturbance as symptoms and partially suppressed them as SSRI side-effects; it also modestly reduced core symptoms of low mood and loss of interest.
PubMedA psychiatric perspective on insomnia.
89 Citations2001W. Vaughn McCall
Benzodiazepines and nonbenzodiazepine benzidiazepine receptor agonists (BzRAs) have the best evidence for efficacy as hypnotics, although sedating antidepressants are popularly prescribed.
Annals of Clinical PsychiatryThe pharmacologic management of SSRI-induced side effects: a survey of psychiatrists.
86 Citations2002Christina Dording, David Mischoulon +6 more
In an effort to manage most SSRI-associated side effects (with the exception of sexual dysfunction and insomnia), the majority of the clinicians responding to the survey opted to switch agents rather than add a specific medication to the existing SSRI.
Journal of Psychiatric ResearchConcordance between self-report and clinician’s assessment of depression
81 Citations1999Emmanuelle Corruble, Jack Legrand +3 more
Patients over-estimating their depressive symptomatology change relative to the psychiatrist tended to score high on phobic anxiety, Cooperativeness (especially Social Acceptance) and Self-Transcendence (especially Self-forgetfulness) and vice-versa.
Psychotherapy and PsychosomaticsOutcome Definitions and Predictors in Depression
74 Citations1998Joyce Tedlow, Maurizio Fava +4 more
Findings support the impression that how outcome is defined affects the strength and direction of observed relationships with predictive variables.
PubMedSleep in late-life recurrent depression. Changes during early continuation therapy with nortriptyline.
72 Citations1991Charles F. Reynolds, Carolyn C. Hoch +8 more
The sleep of thirty elderly patients with recurrent unipolar depression was examined and the single best correlate of clinical change was prolongation of REM sleep latency, consistent with the concept that anti-depressant drug efficacy may depend upon strengthening of the homeostatic regulation of sleep and upon changes in the REM-sleep regulation.
Journal of Affective DisordersIs extended clonazepam cotherapy of fluoxetine effective for outpatients with major depression?
65 Citations2002Ward T. Smith, Peter D. Londborg +2 more
Extended clonazepam cotherapy of fluoxetine appeared safe and effective for depressed outpatients: it was superior to fluoxETine alone early in treatment and again following fluoxettine dose increase.
Journal of Affective DisordersThe pattern of physical symptom changes in major depressive disorder following treatment with amitriptyline or imipramine
51 Citations1994Regina C. Casper, M M Katz +4 more
The study describes a sequential analysis of depression-related physical symptoms and their relationship to imipramine and amitriptyline plasma levels over 4 weeks of treatment in 79 unipolar and bipolar patients hospitalized for major depressive disorder, suggesting a close link between depressed mood and physical symptoms during recovery from major depressive Disorder.
Psychology and Psychotherapy Theory Research and PracticeComparison of self‐rated and clinician‐rated measures of depressive symptoms: A naturalistic study
42 Citations2004Stella Dorz, Giuseppe Borgherini +3 more
It was found that about 18% of patients overestimated and about 15% underestimated their depressive symptomatology (SCL-90 depression subscale) relative to the psychiatrist's assessment, while approximately 75% of participants were correctly classified.
SLEEPEffects of Flurazepam and Zolpidem on the Perception of Sleep in Insomniacs
39 Citations1995Wallace B. Mendelson
Journal of Clinical PsychopharmacologyNefazodone in Major Depression
17 Citations1998Karl Rickels, Edward E. Schweizer +5 more
Compared with nefazodone 200 mg given as monotherapy, insomnia was significantly improved--not only by triazolam, but also alprazolam and diazepam, But not temazepam, which means that one should expect an improved sleep pattern initially, but at the cost of clinically relevant daytime sedation.